Home > National Drug Code (NDC) > Ondansetron

Ondansetron - 10019-905-01 - (Ondansetron Hydrochloride)

Alphabetical Index


Drug Information of Ondansetron

Product NDC: 10019-905
Proprietary Name: Ondansetron
Non Proprietary Name: Ondansetron Hydrochloride
Active Ingredient(s): 2    mg/mL & nbsp;   Ondansetron Hydrochloride
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ondansetron

Product NDC: 10019-905
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077541
Marketing Category: ANDA
Start Marketing Date: 20101119

Package Information of Ondansetron

Package NDC: 10019-905-01
Package Description: 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-905-01) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-905-17)

NDC Information of Ondansetron

NDC Code 10019-905-01
Proprietary Name Ondansetron
Package Description 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-905-01) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-905-17)
Product NDC 10019-905
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Ondansetron Hydrochloride
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20101119
Marketing Category Name ANDA
Labeler Name Baxter Healthcare Corporation
Substance Name ONDANSETRON HYDROCHLORIDE
Strength Number 2
Strength Unit mg/mL
Pharmaceutical Classes Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]

Complete Information of Ondansetron


General Information